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Implantation of the mouse blastocyst into a progesterone primed uterus 
occurs after an increase in circulating estrogen levels in the mouse. The cellular 
events first require changes in the uterine epithelial surface permitting attachment 
of the blastocyst. Changes induced by gonadal steroids are well documented in 
both the epithelium and stroma of the intact uterus, however, very little is known 
about how these changes are mediated. There is accumulating evidence in rodents 
that the proliferative response of uterine epithelium to estradiol in vivo probably 
requires interaction with the underlying stroma during development, before sexual 
maturity and at adulthood. A method of directly observing the cell types prolif­
erating in response to estradiol in vitro was used in order to determine whether 
stromal interaction is required for epithelial response to estrogen. Primary cultures 
of uterine epithelium and stroma from either immature or adult mice in early es­
trus were maintained in a defined, serum-free medium, and were treated on day 2 
of culture with 8 x 10-9 M 1713-estradiol or control medium for 24 hours. Uterine 
epithelial and stromal cells were examined in monoculture and coculture, using cel­
lular morphology and immunolocalization of cytokeratin to distinguish epithelial 
cells from stromal cells. Proliferation was assayed by antibody labeling of incor­
porated 5-bromo-2-deoxyuridine in individual cells. Estradiol-treatment increased 
the proliferation of the epithelium in cocultures of cells isolated from immature 
or adult mice (on. the average of 2-fold and 4-fold, respectively).  Proliferation as high as 7-fold above controls occurred.  Estradiol also stimulated proliferation 
in the stromal cells in coculture, albeit to a lesser extent. Treatment with 17,Q­
estradiol suppressed proliferation of epithelial monocultures by 50% and stromal 
monocultures by 30% for cells isolated from immature mice. Estrogen-treatment 
of cells isolated from adult mice also decreased the proliferation of epithelial and 
stromal monoculture. The response of epithelium to estrogen in either cocultures 
or monocultures was greater than that of stromal cells. Density of the culture af­
fected the baseline proliferation, which increased with increasing densities within 
the optimal range, and decreased at very high or very low culture densities. Cells 
were grouped from cocultures isolated from immature mice according to the type 
of cell and the type of cells each contacted directly. Epithelial cells that had phys­
ical contacts to both stromal and epithelial cells in the estrogen-treated coculture 
accounted for approximately 80% of the estradiol-stimulated proliferation in these 
cocultures. The specificity of the estradiol stimulation was shown by the addition 
of either 10-5 or 10-7 M tamoxifen to cocultures with estradiol, which prevented 
the estradiol-stimulated increase in proliferation. These results demonstrate that 
stromal cell interaction is necessary for the estrogen-induced proliferation of ep­
ithelium in vitro, and that this mediation requires cell contact with the epithelium 
or stromal-mediated changes in the microenvironment immediately around the 
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Chapter 1 
Steroidal ly Induced Cellular Changes in the
Endometrium During the Estrous Cycle in the
Mouse A Review of the Literature
1.1 Major Cell Types and Interactions within the En­
dometrium 
1.1.1 Cell Types within the Endometrium 
The uterus is composed of two compartments: the endometrium and myometrium. 
The endometrium consists of epithelium, stroma and the basement membrane 
which separates the two tissue types. The myometrium contains circular and lon­
gitudinal smooth muscle layers separated by and surrounded by connective tissue. 
The simple, columnar epithelium which lines the luminal surface of the 
uterus has a number of tubular invaginations known as uterine glands. The num­
ber of glands present in the uterus varies among species from a relatively low 2 
number of straight glands in rodents to a high number of tortuous glands present 
in primates [1]. Luminal and glandular epithelial cells have typical junctional com­
plexes consisting of tight junctions, gap junctions and desmosomes on the lateral 
regions of their plasma membranes. These allow epithelial cells to maintain the 
integrity of the sheet and communicate with each other. Apical and basal surfaces 
of the cells are different in form and function. This polarity has been demonstrated 
by primarily basal uptake of methionine and secretion of prostaglandins, primarily 
apical secretion of proteins, and localization of a number of membrane components 
including apically located cell adhesion molecule-105 (CAM-105) [2, 3, 4]. 
Fibroblasts make up the cellular portion of the stroma and secrete the 
matrix in which they are embedded. Primary components of the stromal matrix are 
collagen type I, chondroitin sulfate proteoglycans, and fibronectin, while laminin 
and collagens type III, V and VI are present in lesser quantities [5, 6, 7]. Vascular, 
lymphatic and neural structures are also present in the stromal layer, as in other 
loose connective tissues. 
The basement membrane separating the epithelium and stroma is a mesh 
of fibers produced by both cell types.  Basement membrane components pro­
duced by epithelium are referred to as the basal lamina. Collagen IV, laminin, 
entactin/nidogen, and heparan sulfate proteoglycans make up the basal lamina pri­
marily, but stromal cells may produce small amounts of these products as well [8]. 
Below the basal lamina layer of basement membrane is the the lamina reticularis, 
which' is produced by the stromal cells, and resembles the stromal extracellular 3 
matrix. Collagen I,  fibronectin and chondroitin sulfate proteoglycans constitute 
the lamina reticularis [9, 10]. 
1.1.2  Communication between Epithelial and Stromal Cells 
Communication between cells could occur via direct contact between cells, through 
changes in attachments to basement membrane, or changes in molecules in the 
cell surface/basement membrane microenvironment. Extracellular matrix (ECM) 
molecules include basement membrane components as well as other matrix molecules 
such as those in the stromal matrix. Basement membrane components may be in­
volved in facilitating communication between epithelial and stromal cells through 
intimate connections between basement membrane molecules, other ECM molecules, 
the basal epithelial surface, and the proximal surface of the stromal cells. In or­
der to maintain these contacts, ECM components contain sequences which bind 
specifically to cell membrane proteins or regions on other matrix components. For 
instance, laminin binds collagen IV, the cell surface, and heparin [11]. Fibronectin 
binds to cellular receptors called integrins, collagen, heparan sulfate proteoglycans, 
and fibrin [12]. Nidogen binds collagen IV and laminin [13]. 
The presence of a basement membrane in culture as well as the type of ECM 
molecules in the basement membrane can influence morphology and physiology of 
the attached cell. Normal rat hepatocytes maintain mRNA synthesis and stability 
typical to their in vivo tissue state only when both a hormonally defined serum-
free medium and a basement membrane are provided for the cultured cells [14]. 4 
Culture of insulinoma cell lines on Matrigel, an artificial basal lamina-like matrix 
isolated from Engelbreth Holm Swarm tumors of mice, improved their production 
of insulin and response to glucose [15]. Mammary epithelium grown on mam­
mary basement membrane maintains a  160-fold higher production of casein and 
lactalbumin than cells cultured on plastic [16]. Pulmonary epithelial cells cultured 
on laminin maintained differentiated characteristics, whereas pulmonary epithelial 
cells cultured on fibronectin lost their differentiated state [17]. 
Rat uterine epithelial cells remain polarized (have defined apical and basal 
surfaces like in vivo) when cultured on Matrigel-coated filters. This polarization 
was demonstrated by greater protein secretion from the apical, as compared to 
the basal surface (9:1), and a larger uptake of radioactive methionine from the 
basal, compared to the apical surface (5:1) [4].  Polarized epithelial cells secrete 
from their apical surfaces molecules known to be upregulated by estrogen such 
as prostaglandin F2ck (PGF2a), complement component C3, the secreted portion 
of the IgA receptor, and uterine secretory protein-1 (USP-1) [2, 3, 4]. CAM-105 
is also present on the apical surface of the polarized cells [4]. Uterine epithelial 
cells in these experiments were always cultured in the presence of 17/3 estradiol, 
so the possibility that these secreted proteins could be produced in this culture 
situation without estrogen-stimulation cannot be ruled out.  However, the lack 
of production of PGF2e, by non-polarized epithelium cultured in the presence of 
estradiol does confirm that the polarized morphology resulting from culture on 
Matrigel and access to medium through the basal cell surface was necessary for at least some physiological conditions of the cell [3]. 
The matrix can alter gene regulation by hormones in vitro in a tissue specific 
manner to recreate a more in vivo-like response [18]. Mammary epithelial cells iso­
lated from pregnant or lactating mice and cultured on ECM produce large amounts 
of transferrin mRNA in response to lactogenic hormones as in vivo [16]. Mammary 
epithelium does not show this response to hormones in the medium when cultured 
on plastic. Hormones can also alter the composition of the extracellular matrix 
through stimulating deposition of new matrix molecules or degradation of the old 
matrix molecules.  Fibroblasts increase fibronectin biosynthesis and osteoblasts 
increase collagen I biosynthesis in response to glucocorticoids [19, 20]  Estriol, 
17,6- estradiol, or interleukin 1,3 stimulated collagenase production by cervical cells 
in culture [21].  Changes in composition of the matrix could in turn alter the 
interactions between epithelial and stromal cells. 
It is unclear how hormonal response is modified by matrix components. Two 
possible mediators are extracellular matrix-induced cell shape change and changes 
in the population of growth factors bound to ECM molecules within the basement 
membrane [18].  Folkman and Moscona demonstrated that cell shape can alter 
proliferation [22]. They cultured different cell lines on coated plastic which created 
varying degrees of adherence by the cells.  Several different cell shapes ranging 
between flattened and round resulted, and as the cells became more flattened they 
had a higher incidence of cell division as measured by incorporation of tritiated 
thymidine. Matrix induced shape change and growth factors may have synergistic 6 
effects on cells. Corneal epithelium cultured on plastic has a flattened morphology 
and does not increase proliferation in response to epidermal growth factor (EGF), 
but is sensitive to fibroblast growth factor (FGF). When corneal epithelium is 
cultured on collagen which allows a columnar shape to be maintained, the cells do 
not proliferate in response to FGF, but proliferate when EGF is added [23]. 
Extracellular matrix molecules often contain binding sites for growth fac­
tors or sequences which themselves can cause growth factor-like effects by binding 
to growth factor receptors. Growth factors effect cell division by causing cells to 
become competent to divide (an early event in GO, or by causing the progression of 
competent cells through G1 from an arrested point [24]. Heparan sulfate proteogly­
can chains contain sequences which bind to basic fibroblast growth factor (bFGF), 
albeit -with a lower affinity than that of its dominant cell surface receptor [25]. One 
member of the EGF family, HB-EGF, binds heparin [26]. Glycosaminoglycans iso­
lated from the ovary interact or complex with EGF as shown by the co-precipitation 
of angiogenic activity with the glycosaminoglycan fraction [27]. Laminin has been 
shown to contain EGF-like repeats, which can stimulate DNA synthesis only in cell 
lines that contain EGF receptors [28]. Nidogen and the fibronectin receptor have 
also been shown to contain EGF-like repeats [13, 29]. Matrigel has been shown to 
contain bFGF, transforming growth factor-beta (TGF -/3) and tissue plasminogen 
activator (TPA) [25, 30, 31]. There is evidence to suggest that either EGF, TGF-
a, which has similar structure and function to EGF and acts through the EGF 
receptor, or both are present in Matrigel since cultured kidney epithelium form 7 
tubules on Matrigel or on protein-stripped Matrigel with either EGF or TGF-a 
added [31].  These observations have been used to suggest that the ECM could 
act as a reservoir for growth factors. Changes produced in the microenvironment 
around the cell including degradation of ECM molecules by the steroid-stimulated 
release of hydrolases from the cell could release growth factors bound to the ECM. 
These growth factors then would be free to bind the higher affinity cell surface 
receptors and facilitate cellular changes such as progression from G, to G1 of the 
cell cycle. 
Epithelial and stromal cells directly contact one another in at least some 
species besides sharing connections to ECM molecules.  Transmission electron 
micrographs of human endometrium showed that basilar epithelial projections 
through the basal lamina increased in response to increasing plasma estrogen levels 
during the menstrual cycle. Cytoplasmic projections are sparse during the luteal 
phase, but increase in number and form increased numbers of gap junctions with 
other epithelial processes during the proliferative phase when estrogen is highest. 
These complex projections also connect with stroma cell projections growing up 
through the basal lamina during the mid-proliferative phase [32]. Gap junctions 
allow the passage of chemical or electrical signals between cells, and have been 
implicated in cell communication [33, 34, 35]. Thus there are many possible ways 
for the matrix and/or stroma to communicate with the epithelium; an interaction 
that may be necessary for the epithelial response to estrogen. 8 
1.2  The Estrous Cycle in the Laboratory Mouse 
The estrous cycle is the female reproductive cycle in non-primate mammals. It is 
characterized by the remodeling and slight thickening of the uterine endometrium 
so that it can support the implantation and growth of an embryo in the event 
of fertilization during estrus.  Growth of the endometrium is due to hypertro­
phy (increased cell size due to higher fluid volume of the organ) and hyperplasia 
(increased cell division) of both epithelial and stromal cell layers in response to 
increased estrogen and progesterone. 
The following description of the estrous cycle summarizes the most gener­
ally accepted understanding of the process [36, 37, 1, 38]. The estrous cycle is 
controlled by changes in secretion of luteinizing hormone (LH) and follicle stim­
ulating hormone (FSH) from the anterior pituitary, which cause changes in the 
plasma levels of estrogen and progesterone secreted by the ovary (Figure 1). Pul­
satile releases of luteinizing hormone releasing hormone (LHRH) from the arcuate 
nucleus of the hypothalamus cause the pulsatile release of LH and FSH from the 
anterior pituitary. Several neurotransmitters are involved in the release of LHRH, 
including noradrenergic, dopaminergic, and opioid neuronal networks. The mech­
anism of control of LHRH release, and how estrogen contributes by both positive 
and negative control is not fully understood. The release of FSH is also under 
positive control by activin and negative control by inhibin. Inhibin and activin 
are peptide hormones produced by the ovary, and differ only in one  of the two 9 
peptide subunits from each other. The production of inhibin is probably stimu­
lated by gonadotropins. The ovary also produces /3-endorphin, adrenocorticotropin 
hormone (ACTH), a-melanocyte stimulating hormone (a-MSH), vasopressin, and 
oxytocin.  However, the physiological role of ovarian peptide hormones is still 
unclear. The release of LH and FSH occurs approximately every hour (70-100 
minutes), and each subsequent pulse contains increasingly larger amounts of LH 
and FSH. The amount of FSH released is approximately half of LH released in 
any pulse. Luteinizing hormone receptors are present on the plasma membranes of 
thecal, granulosa, and stromal cells in the ovary. The binding of LH to its receptor 
activates the enzymes needed to convert cholesterol to progesterone in both cell 
types, and the enzymes necessary to convert progesterone to androstenedione. An­
drostenedione in a thecal cell is converted to testosterone, or can be transported to 
a granulosa cell where it is converted to estrone. Testosterone is also transported to 
the granulosa cell where it can be aromatized to 170-estradiol. Aromatase activity 
is stimulated by the binding of FSH to its receptors which are present exclusively 
on granulosa cell membranes. The enzymes responsible for converting cholesterol 
to progesterone in the granulosa cell are also stimulated by FSH. Estrogen causes 
the increase of estrogen receptors in LH responsive cells of the ovary which pro­
duce estrogen, therefore, the signal is amplified between diestrus and proestrus and 
estrogen release increases at a higher rate. 
The mouse completes an estrous cycle every four to five days as measured by 
the state of the the vaginal epithelium which can be assessed by flushing the vagina 10 
with water or saline and examining the fluid microscopically [39]. The correlation 
between vaginal lavage and the histological state of the uterus and the vagina was 
described in 1922 even though the hormones responsible had not yet been dis­
covered [40]. During diestrus the vaginal lavage is dominated by leukocytes, and 
contains only few rounded epithelial cells. The high number of leukocytes in the 
lavage occurs because the cervical epithelium, like the uterine endometrium, is 
thinnest at this stage allowing the leukocytes to infiltrate the epithelium more eas­
ily. Plasma progestagen levels are slightly elevated during metestrus and diestrus 
due to progesterone and 20a-dihydroprogesterone secretion from the interstitial 
cells of the ovary [36]. These cells have been referred to as the "permanent corpus 
luteuth" of rodents [41]. As the cycle progresses, the vaginal lavage shows increasing 
numbers of rounded epithelial cells, and by the end of early estrus, the presence of 
cornified epithelial cells. The increase of epithelial cells in the lavage is indicative 
of the estrogen-promoted growth of the epithelial layers of both the vagina and 
uterus [42, 36]. Estrogen also causes the cornification of the vaginal epithelium 
after the stratified squamous epithelium reaches a critical thickness [43, 44, 45]. 
Estrus vaginal lavage contains only cornified epithelial cells. Leukocytes collect in 
the subepithelial zone during metestrus and invade the epithelial layer [40]. The 
reappearance of leukocytes in the lavage occurs in metestrus when degeneration of 
the epithelial layers of the vagina and uterus is taking place. Flakes of the uter­
ine luminal epithelium and layers of cornified vaginal epithelium are lost during 
metestrus of each cycle, then replaced during the next cycle through stimulation 11 
by estrogen. However, the luminal epithelium continues to be present as a layer 
throughout the mouse estrous cycle [46]. 
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Figure 1. Relative changes in the concentrations of estrogen and progestagens during the rat 
estrous cycle and early pregnancy (reproduced from Svalander [47]). 
1.3  Molecular Mechanisms of Steroid Action 
Steroid hormones exert their effects on target cells by binding to specific receptors. 
Immunohistochemical studies have localized progesterone, estrogen, and androgen 
receptors to the cell nucleus even in the absence of hormone [48]. Several studies 
using anti-glucocorticoid receptor antibodies reported glucocorticoid receptors in 
the cell cytoplasm [49, 50, 51, 52]. Another immunohistochemical study showed 
that this cytoplasmic immunoreactivity is due to diffusion of the glucocorticoid 
receptor from the nucleus in the absence of hormone [53]. And recently, another 
immunocytochemical study has localized the unliganded glucocorticoid receptor 12 
exclusively to the nucleus in hepatoma cells [54].  Therefore, the glucocorticoid 
receptors are probably also localized to the nucleus regardless of the presence of 
hormones. There are cases where steroids bind to a receptor located on the plasma 
membrane as well. Frog eggs have progesterone receptors on their plasma mem­
branes that bind progesterone released from the ovary, and stimulate germinal 
vesicle breakdown and release of the primary oocyte from meiotic arrest [55]. Cor­
ticosterone binds to sites on the neuronal cell membrane in the newt brain and 
rapidly suppresses male reproductive behavior [56]. Steroid receptor proteins be­
long to a large superfamily of ligand-activated DNA binding transcription effectors 
including the vitamin D3 and vitamin A receptors, Drosophila juvenile hormone 
receptor, thyroid receptor, orphan receptors which are similar in structure to the 
family but do not have identified ligands, as well as the glucocorticoid receptors 
and sex steroid receptors [57, 58]. 
Steroids circulate in the plasma primarily bound to steroid binding pro­
teins (SBP). Only 1-2% of testosterone, estrogen, and progesterone are not bound 
to SBP in human blood plasma [59]. Measurements of unbound estrogen in rat 
plasma have shown that the free fraction of estrogen is < 1% in immature rats, 
but rises to 4% at maturity [60].  Originally, the consensus was that steroid 
binding proteins acted as a simple buffer reserve for sex steroid, and the un­
bound steroids were the active portion of the hormonal pool [59].  However, 
the bound steroid may be the active fraction. Two types of evidence indicate 
that steroid binding proteins may affect transfer of hormone to the cell:  (1) 13 
Steroid binding proteins have been detected in cells other than the site of syn­
thesis [61, 62, 63, 64].  (2) Membrane specific binding sites for steroid binding 
proteins have been isolated from cell membranes from hyperplastic prostate, de­
cidual endometrium, pre-menopausal endometrium, endometrial adenocarcinoma, 
liver, and post-menopausal breast [65, 66, 67]. Two opposite models have been pre­
sented to explain these evidence: (1) The model derived from research on prostate 
states that the binding of steroid-SBP to a membrane binding site for  SBP in­
hibits entry of the steroid into the cell [68]. (2) The model derived from research 
on decidual endometrium states that binding of the steroid-SBP to its binding site 
facilitates steroid transport into the cell [66]. 
The activated steroid-receptor complex binds to the DNA and activates a 
cascade of gene transcription by a well studied series of events. The consensus is 
that steroids enter the cell by diffusion through the plasma membrane and move 
by simple diffusion to the nucleus where they bind the appropriate receptor [58]. 
Some researchers believe that movement through the cytoplasm is facilitated by 
cytoplasmic components. High affinity binding sites for estrogen and testosterone 
were found on the microsomal membranes of rat uterine tissue and ventral prostate, 
respectively [69]. These sites were hypothesized to act as carriers to move steroids 
into the nucleus. 
The unliganded steroid receptor protein exists complexed to several pro­
teins including heat-shock proteins 70 and 90, and is unable to bind DNA in this 
state [58]. The biliding of the steroid molecule to the receptor causes dissociation 14 
of other proteins and mediates receptor activation through allosteric change in the 
receptor followed by a covalent modification [58]. The trans-activation activity of 
the estrogen receptor is located on the C-terminus of the receptor and becomes 
active only after ligand binding [70].  It is generally accepted that phosphoryla­
tion of the receptor by serine and threonine protein kinases (also tyrosine on the 
estrogen receptor) have some role in the final activation of the steroid/receptor 
complex [57, 71]. The receptor/steroid complex dimerizes then binds to enhancer 
sequences called steroid response elements which are located 5' to or within the 
genes that the steroid activates or represses in the cell. These enhancer regions are 
palindromic and contain two half-sites, each of which binds a DNA binding region 
on one of the dimerized receptor proteins through the interaction of the DNA with 
two zinc finger motifs on each receptor. Finger swap experiments have shown that 
the amino terminal zinc finger determines the target gene specificity [57]. Ligand­
receptor-complex binding to the DNA activates a cascade of gene transcription 
thought to be brought about by the stabilization of transcription factors situated 
at the promoter of the gene with the bound steroid response element. The stabi­
lization could be brought about by unspecific or ubiquitous interactions between 
transcription factors and the hormone receptor [72].  Some of these transcripts 
code for regulatory proteins themselves (early gene products) which activate other 
tissue specific structural genes (late genes) associated with the steroid action. 
Through conventional methods steroids cannot effect changes in cells which 
do not contain receptors.  Therefore, autoradiographic or immunohistochemical 15 
analysis of tissues, or quantitative assays for the appropriate receptor are com­
monly performed to determine whether the cell is able to respond directly to 
steroids. Receptor isolation techniques allow a portion of the estrogen or proges­
terone receptors to leak out of the nucleus into the cytoplasmic fraction. Therefore, 
the total number of receptors is usually estimated by adding the number of recep­
tors from both fractions together.  Sometimes receptors isolated in the nuclear 
fraction are the only receptors measured because such receptors are a better mea­
sure of those that are biologically active and closely associated with the chromatin 
at the time of extraction. 
When two or more steroid hormones are accessible to cells, there can be syn­
ergistic responses by cells which are different from the response to each individual 
hormone. For instance, when ovariectomized mice injected daily with three doses 
of progesterone before injection of a single dose of estradiol, the number of mitoses 
in the uterine stromal cells increase dramatically (1.4 +0.2 to 143.0 +17.3 stromal 
mitoses per uterine section) [73]. Without progesterone priming mitoses increase 
slightly above untreated controls (0.2 ±0.2 to 4.5 +1.1 stromal mitoses per uterine 
section).  Administration of a large dose of dexamethasone 20-25 minutes prior 
to estrogen injection inhibits estradiol induced uterine weight gain [74]. Dexam­
ethasone administration at various times after estradiol injection also reduced long 
term growth in the uterus [74]. Through studies measuring the quantity of nuclear-
bound, receptor-estrogen complexes and the baseline rates of proliferation, it has 
been hypothesized that the effect of dexamethasone on proliferation is indirect and 16 
actually affects estrogen-independent proliferation [75, 74]. Hydrocortisone is less 
potent than dexamethasone, however, hydrocortisone may decrease the baseline 
level of cell division in cultures where it is a medium supplement. Hydrocortisone 
is a common additive to serum-free medium, and glucocorticoid-receptor binding 
can cause the upregulation of the glucocorticoid receptor in stimulated cells [76]. 
Also, the location of a high-affinity progesterone-binding site on the glucocorticoid 
receptor was discovered and characterized in AtT-20 cells [77].  So the amount 
of progesterone binding to the glucocorticoid receptor may also be increased by 
the regular addition of hydrocortisone to the media, and make measurements of 
progesterone action based solely on progesterone receptor extraction and analysis 
less accurate. 
1.4  Estrogen and Progesterone Action in the Endometrium 
Estrogen and progesterone cause endometrial cells to undergo hypertrophy, hyper­
plasia, initiate gene activation for a number of molecules, and increases vascular­
ization of the endometrium following the release of estrogen-induced chemotactic 
factors which cause neutrophil infiltration of the stroma. Progesterone's primary 
target is the stroma, however, it also acts to decrease some estrogenic effects in the 
epithelium [78]. Estrogen's primary target is the epithelium where it causes upreg­
ulation of steroid receptors, stimulates transcription of many growth factors, their 
receptors, proto-oncogene products, cell surface molecules and secretory products 17 
in rodents [78, 79, 80, 81, 82, 83, 84, 85]. 
Estrogenic responses are grouped into early and late effects. Early responses 
include imbibition of water and increases in blood flow resulting in hypertrophy, 
glucose oxidation, lipid synthesis, RNA polymerase activity, incorporation of nu­
cleotide precursors into RNA, incorporation of amino acids into proteins, and tran­
scription and translation of oncogene products including some growth factors and 
their receptors.  These events occur 1-6 hours after estrogen treatment.  Early 
responses can be induced by weak estrogens  such as estriol and estrone. These 
estrogens have a lower affinity for the estrogen receptor than 17,3-estradiol, and 
are retained in the nucleus less than six hours.  Late responses include hyperplasia, 
continued stimulation of polymerase activity, and increases in DNA and protein 
synthesis. Estrogen must be retained in the nucleus for 6-8 hours for the late re­
sponses to occur. Strong estrogens such as 170-estradiol or the synthetic estrogen 
diethylstilbestrol stimulate late effects. A single dose of estriol or estrone cannot 
stimulate late effects ordinarily. However, if the dose of estriol or estrone is large 
enough or administered multiple times , then the hormone continues to occupy the 
receptor and late effects can be stimulated. Estrone can also be converted into 
17/3 estradiol, which can initiate late responses. Estrone is a more potent stim­
ulator of proliferation in the mouse uterine epithelium than estriol [86], inducing 
approximately 60% of the proliferative response, and 80% of the RNA transcription 
that 170-estradiol stimulates [87, 88]. Estriol is more efficient at inducing protein 
synthesis than estrone [89]. It stimulates hyperplasia in the mouse uterine epithe­18 
lium  ,  but does not protect against apoptosis as 17/3-estradiol does [90]. Some of 
the relative potencies of estriol and estrone may be due to the differences in the 
vehicles (saline or oil) in which the hormones were dissolved and injected [91]. Di­
ethylstilbestrol and 17/3-estradiol are the estrogens most commonly used recently, 
since they elicit all the estrogenic responses strongly in vivo. 
The earliest noted transcriptional regulation by estrogen is an increase in 
proto-oncogene products which act as transcription activators themselves. These 
include c-fos, c-myc, c-jun, jun-B, jun-D and H-ras [92, 82, 93]. Maximal increases 
in mRNA of the fos and jun family occur three hours after 17/3- estradiol stim­
ulation. These products are the primary constituents of the AP-1 transcription 
activator, which could be involved in promoting the G, to G1 transition causing 
quiescent cells to enter mitosis, or in promoting a number of other gene functions. 
Jun-B can act as a negative regulator of c-jun, so that AP-1 may perform dif­
ferent functions if levels of its constituents are altered [94, 95]. C-fos, c-jun and 
c-myc can also be regulated by tissue plasminogen activator in the endometrium, 
showing that non-steroidal activation may compete with steroidally induced acti­
vation to provide cross-talk between estrogen and other factors in the endometrial 
environment [94]. 
Other early responses include stimulation of growth factors and their re­
ceptors.  Estrogen has been shown to stimulate EGF, insulin-like growth fac­
tor (IGF), their receptors, TGF -/3, and colony stimulating factor-1 (CSF-1) in the 
endometrium. Both EGF and IGF stimulation can cause hyperplasia. Epidermal 19 
growth factor stimulated cell division in cultured endometrial cells was inhibited 
by concurrent treatment with the antiestrogen, hydroxytamoxifen [80]. Basic fi­
broblast growth factor has also been shown to be present in the basal lamina and 
matrix of the rodent uterus, but the amount does not change during the estrous 
cycle [96]. 
The different early responses may work as part of a cascade to induce late 
responses to estrogen. Estrogen stimulation of growth factors or their receptors, 
and correlations between proto-oncogene expression and growth factor expression 
have been shown in other cell and organ types. Estrogen induction of DNA synthe­
sis has been shown to be mediated by TGF-0 in rat granulosa cells in culture [97]. 
Transforming growth factor-fi stimulates the production of the extracellular ma­
trix components: collagen, fibronectin, integrin, tenascin, and proteoglycans [98]. 
It can also inhibit or stimulate cell division depending on cell type and cell lo­
cation [99].  The varying effects which TGF-0 can initiate, and the fact that it 
is stimulated by estrogen in the endometrium make it a possible mediator of at 
least some of the diverse responses of the endometrium to estrogen during estrous 
cycling and preparation for pregnancy. The growth factors that are induced by 
estrogen themselves induce "estrogenic" type responses. EGF stimulates tissue 
plasminogen activator mRNA in rat granulosa cells. EGF, IGF-1 and cyclic AMP 
upregulate progesterone receptors in cultured endometrial cells, all of which can 
be prevented by the addition of antiestrogens (ICI 164,384, tamoxifen,and 4-0H­
tamoxifen). Elevated TGF-#1 and 3 are associated with ras and myc increases in 20 
reconstituted mouse prostate [100]. 
Estrogen also induces changes in cell surface and secretory products. Changes 
in cell surface molecules may influence cell interactions with other cells and the 
basement membrane. Changes in association with basement membrane molecules 
can facilitate migration, cell cycling, or other processes such as differentiation. 
Estradiol also increases the basally expressed syndecan, which binds cells to col­
lagens and fibronectin, and integrin, the receptors for collagen, fibronectin, and 
laminin respectively [101, 102, 103]. Estrogen stimulates the turnover of heparan 
sulfate proteoglycan (HSPG) chains on the luminal surface of the epithelium [104], 
and the production of uterine secretory protein-1 (USP-1) in rodents [85]. 
Effects of estrogen on the lipid metabolism of the rat uterus in vivo were 
noted as early as 1972 [105]. Estrogen stimulates the incorporation of tritiated 
inositol into inositol phospholipids and the breakdown of phosphatidylinositol into 
inositol polyphosphates in vivo in the mouse uterine epithelium [106, 107]. These 
effects occur 6-9 hours after injection of the hormone and have been blocked by 
antiestrogen or progesterone treatment, so it is unlikely that they are the result 
of non-traditional estrogen action pathways [108, 107]. Because this phospholipid 
turnover occurs before the onset of estrogen-induced DNA synthesis, membrane 
signal transduction may have some role in the stimulation of cell division by es­
trogen. 21 
1.5  Estrogen and Cell Cycling in the Mouse Endometrium 
Estrogen was first described as the factor which initiated estrus and as a "stimu­
lator of mitoses in special tissues" [109]. Allen and Doisy described the extraction 
and partial purification of "theelin" from ovine liquor folliculi in 1923 [109]. In­
jection of this preparation into ovariectomized mice or rats stimulated estrus, as 
measured by vaginal lavage and histological examination of the uterus and vagina. 
Injection of "theelin" into a variety of strains of ovariectomized mice produced in­
creased numbers of mitoses in the epithelia of the uterus, vagina, and breast [42]. 
Allen described the increase in mitoses as a "true hyperplasia" because the number 
of mitoses was unusually high for the tissue and a significant amount of new tissue 
was produced [42]. 
The number of mitoses in the luminal epithelium of ovariectomized mice 
treated with estradiol was higher than in ovariectomized controls, and increased 
as the dosage of estradiol increased [73]. A single injection of 0.1 pg of estradiol 
per mouse increased the mean number of mitoses per 5 am section of uterine horn 
from zero to 50. Doses as high as 2.5 ,ug were injected, but could not increase the 
mean number of mitoses any higher than 65 per section. The number of mitoses in 
the epithelium also increased in a time dependent manner after estrogen injection. 
The number of mitoses began to increase at 12 hours, reached a maximum near 24 
hours, and did not decrease to control levels until after 30 hours post-injection [42, 
110, 86]. These investigations utilized colchicine to block all mitoses two hours 22 
before the death and histological examination of the animal. 
For over 50 years it has been known that the cells of the uterus maintain a 
low level of cell division. The number of mitoses in one 10 it section of mouse uterine 
horn varies from 0.3% to 4% during the estrous cycle [111]. The DNA content of 
the uterus also remains relatively constant with the lowest content occurring at 
diestrus as measured by incorporation of radioactive phosphate [111]. Most studies 
of cell division in the uterus use some way of enhancing these numbers by labeling 
S-phase or blocking cytokinesis with colchicine or colcemid. It is also necessary 
to address the responses of the different cell types of the uterus separately. A 
large increase in cell division in the epithelium appears as a very small change in 
the entire uterus if it is the only tissue responding to the stimulus because the 
epithelium only constitutes 5-10% of the uterus by mass [112]. 
The establishment of estrogen as a stimulator of cell division initiated re­
search on how estrogen affected the cell cycle. The DNA content of the uterus 
of the estrogen- treated ovariectomized mouse did not change appreciably, but the 
RNA content increased with estrogen treatment [113]. The nuclear volume of the 
uterine epithelial cells increased cyclically during the estrous cycle with a peak vol­
ume during metestrus, approximately 24 hours after the estrogen peak in the cycle 
indicating that changes in nuclear volume are within the time of estrogen stim­
ulated events [114, 111]. These data led Salvatore to propose that estrogen was 
responsible for the replication of the genome, and that DNA replication may not 
always be immediately followed by mitosis [115]. Later experiments showed that 23 
after DNA was synthesized, the cell would continue through mitosis and divide 
because the amount of DNA per cell did not change according to the photoelectric 
density of the Feu lgen reaction of the uterine cell nuclei [116].  Therefore, each 
round of DNA synthesis must be followed by mitosis without the cell entering 
a quiescent period in G2. Bullough suggested that estrogen  stimulated mitoses 
through the activation of the glucokinase pathway and subsequent flow of energy 
into the cell allowing the synthesis of DNA followed by mitosis [117]. This assumed 
that a large population of uterine epithelial cells were ready to enter S-phase when 
the cell energy increased. Swann maintained that this was an unlikely mecha­
nism of estrogen action in tissues with low mitotic indices, such as the uterus, and 
that instead estrogen caused a switch in the cell metabolism to one that preferred 
synthesis of DNA and proteins necessary for mitosis [118]. 
Interest in how a hormone affects the different stages of the cell cycle fueled 
research about the cell cycle in unstimulated and stimulated epithelial and stromal 
cells. Injection of ovariectomized mice with estrone did not shorten mitosis, but did 
decrease the length of interphase in the uterine epithelial cells [110]. The average 
lengths of the cell.cycles were estimated for luminal and glandular epithelial cells 
to be 270 hours and 156 hours, respectively [119].  Das stated, however, that 
the cell cycle was much too variable to obtain an accurate estimate, but that 
he could conclude that estrogen shortened the overall cycle time [119].  Other 
estimates of the length of the epithelial cell cycle have ranged from 82 to 757 
hours, to illustrate the extent of the variation possible [110, 120, 87, 121, 122, 123]. 24 
Since Alfert had shown that G2 was not appreciably long, it was probable that 
Gi and/or S-phase was shortened by estrogen to cause the decrease in the cycle 
length [116]. Estimates of the mean length of S-phase and G1 varied considerably 
between researchers. This was attributed to differences in the type of estrogen 
used, strain of mouse used, and method used to determine to the lengths of the 
cell cycle stages [119]. Estimates of the mean length of S-phase in the unstimulated 
epithelial cell varied from 5 to 10.5 hours, and in the estrogen-stimulated cell from 
2.2 to 7.7 hours [110, 120, 87, 121, 122, 119, 124].  Each report demonstrated 
that the mean time of S-phase was decreased by estrogen-treatment. This was 
most likely due to the elimination of longer S-phases in unstimulated cells, rather 
than an overall shortening of S-phase in each cell because labeled mitosis curves 
generated in the method of Quastler and Sherman showed that the length of S-
phase in unstimulated cells varied and the length of S-phase in estrogen-treated 
cells did not [125, 119, 110]. Quastler and Sherman labeled mouse intestinal cells 
with tritiated thymidine and plotted the percent of labeled mitoses at varying 
times after labeling, then used equations for the kinetics of the cellular population 
to estimate cell cycle duration and stage length in the different cell types present 
in the examined tissue [125]. They state that if the descending and ascending 
limbs of the curve have different slopes, then the length of S-phase is variable. The 
reported mean length of G1 in unstimulated cells was not reported with confidence 
because it varied so widely, but estrogen appeared to shorten G1 [123, 124, 87, 121, 
119, 110, 120, 126]. Smith and Martin later hypothesized that estrogen stimulated 25 
proliferation by increasing the probability that any epithelial cell would become 
committed to one round of cell division [127], and this committment would result 
in the shortening of G1. 
Although most literature states that estrogen only appreciably stimulates 
cell division in the uterine epithelium, a closer examination shows that a small 
amount (1/10 to 1/4 of the stimulation in the epithelium) of cell division is stim­
ulated in the stroma by injection of estrogen alone into ovariectomized mice. The 
number of stromal cells increased from 15 to 20 x 102 at 24 hours after estradiol 
injection [86]. The mean number of stromal mitoses increased from 0.2 ±0.2 to 
4.5 +1.1 per section 24 h after a single injection of estradiol [73]. Ovariectomized 
mice that were injected with [14C]lysine and estradiol showed that the total pro­
tein increased in the stroma half as much as the total protein in the epithelium. 
Also, increases in acidic nuclear proteins and histones occurred to a lesser degree 
in the stroma at the same time as increases occurred in the epithelium [128]. If the 
ovariectomized mouse was first primed with three daily injections of progesterone 
then a single injection caused a synchronized entry of stromal cells into S-phase 
then mitosis for one round of cell division [73]. 
Estrogen may act on the epithelium by first inducing changes in the un­
derlying stroma. Estrogen does not initiate a proliferative response (measured by 
3H-thymidine incorporation) in uterine epithelial cells cultured apart from stroma 
with or without a basement membrane. Increases in hypertrophy, protein synthe­
sis, and secretion can be shown in uterine epithelium cultured on collagen, Matrigel 26 
or nitrocellulose filters coated with Matrigel [4, 3]. However,  the possibility that 
the response when cultured on Matrigel may be due at least in part to the pres­
ence of growth factors sequestered in Matrigel has not been ruled out [25, 30, 31]. 
There was one attempt to ascertain whether estrogen administered to cocultured 
epithelium and stroma caused increased proliferation in the epithelium by mea­
suring incorporation of tritiated thymidine. The total thymidine incorporation for 
the culture increased in the presence of estrogen, though the amount attributable 
to stroma could not be identified [129].  Estrogen receptors do not appear in 
C57BL/J6 mouse uterine epithelial cells until the fifth or sixth day after birth, 
but estrogen administered on the second day after birth, when estrogen receptors 
are present only in the nuclei of stromal cells, does cause  epithelial cell prolifer­
ation [130, 131]. There is also in vivo evidence indicating stromal-epithelial cell 
contact may be necessary for steroidogenic effects in the epithelia of other or­
gans including prostate, seminiferous tubule, vagina and cervix [112]. All of this 
evidence taken together strongly suggests that interaction between stroma and 
epithelium may be necessary for the estrogen-induced proliferation of the uterine 
epithelium in vivo. 27 
Chapter 2 
Estradio1-170 Stimulates Hyperplasia of both
Uterine Epithelial and Stromal Cells in
Coculture, but not in Separate Culture in
Serum-free Defined Medium
2.1  Abstract 
There is indirect evidence that the in vivo proliferative response of uterine ep­
ithelium to estradiol in rodents requires interaction with the underlying stroma 
during development, before sexual maturity and at adulthood. To examine this 
potential requirement directly, the proliferative response of epithelium to estro­
gen in the presence of stroma was carried out in vitro.  Uterine epithelial and 
stromal cells were isolated separately from immature or adult mice, and were 
maintained as monocultures or cocultures in defined, serum-free medium with or 
without 8 x 10' M 17,3-estradiol. To measure proliferation, the incorporation of 
BrdU into the cell's DNA during three hours of labeling was assayed in individual 28 
cells by immunolabeling of incorporated 5-bromo-2-deoxyuridine. Immunolabeling 
of cytokeratin and cell morphology were used to distinguish epithelial from stromal 
cells. Treatment of cocultures with estradiol for 24 hours increased the prolifer­
ation of epithelial and stromal cells relative to controls (1.5- to 4-fold and up to 
2-fold, respectively), whereas, in monocultures of epithelial or stromal cells estra­
diol decreased thenumber of BrdU-incorporating cells (50% and 20% of controls, 
respectively). The epithelial cells within a coculture were catagorized according 
to the type of cells with which they maintained physical contacts. Approximately 
80% of the epithelial cells that responded to estradiol were touching both stromal 
and other epithelial cells. These results demonstrate that stromal cells mediate 
the estrogenic proliferative response in vitro, and that this mediation requires cell 
contact or stroma-mediated changes in the microenvironment immediately around 
the epithelial cell. 
2.2  Introduction 
For over 50 years it has been known that estrogen stimulates increased cell di­
vision, or hyperplasia, in the mouse uterine epithelium in vivo [42]. However, it 
is still unclear whether estrogen acts directly on the epithelium through its own 
receptors or requires interactions with the underlying stromal cells.  It has been 
well documented that 17/3-estradiol administered to ovariectomized or immature 
rodents in vivo causes hyperplasia of the epithelium [42, 73, 86], hypertrophy [86], 29 
and increased vascularization of the endometrium [132, 91].  Estrogen also in­
duces transcriptional activation of genes encoding the progesterone receptor [79], 
estrogen receptor [133], a number of growth factors and their receptors [92, 134], 
enzymes [135, 136, 137, 138, 139, 140, 141, 142, 143, 144], cell surface and secretory 
molecUles [85, 47, 104, 145, 146, 147, 3, 148], and proto-oncogene products thought 
to be involved in mediating other estrogenic responses [92, 93]. 
Recently evidence has accumulated that implicates several growth factors 
and oncogene products as intermediates in estrogen action in several tissues. In 
cultured endometrium, EGF stimulated increased levels of progesterone receptors 
in epithelial cells, and was inhibited by anti-estrogen treatment [80]. An antibody 
specific to EGF inhibited estrogen-induced growth and differentiation of the mouse 
uterus and vagina in vivo [149]. Administration of EGF prevented indomethacin­
induced inhibition of estriol-induced embryo implantation in the mouse [150]. 
Treatment of cultured rat granulosa cells with a neutralizing antibody to TGF-0 
inhibited estrogen-induced DNA synthesis [97]. Estradiol increased the amount of 
TGF -,6 in rat pituitary tumors that were growth-inhibited by estradiol, but did 
not change TGF-# levels in tumors that were insensitive to estradiol [151]. Es­
trogen may also initiate some of its effects through non-genomic mediators. The 
inositol triphosphate signal transduction system was maximally activated in the 
mouse uterine epithelium six hours after injection of either diethylstilbesterol or 
17/3-estradiol [106, 107, 108]. This increase in phosphoinositide turnover was in­
hibited by the administration of anti-estrogens or progesterone [106, 108]. 30 
Hyperplasia is a late response to estrogen, and occurs within a distinct range 
of time after stimulation. Mitoses begin to increase 12 hours after estrogen injection 
with the peak stimulation of cell division occurring at 24 hours and decreasing by 
30 to 36 hours after estrogen administration in vivo [73]. Several peptide growth 
factors and proto-oncogene products that are upregulated by estrogen can also 
induce cell division, including IGF-I [134], EGF [149], Fos, Myc, and the Jun 
family [95].  All of this evidence taken together suggests that the stimulation of 
cell division by estrogen is likely to result from a complex mechanism involving at 
least some of these intermediates. 
Culture of primary isolated cells from the endometrium is an ideal method 
for examining the mechanism of estrogen action without the complex interactions 
that exist in vivo.  However, estrogen does not stimulate uterine [152], mam­
mary [153], or vaginal  [154] epithelial cell division when cultured as epithelial 
monolayers on plastic. Estrogen also does not increase proliferation of vaginal or 
uterine epithelium cultured on collagen or Matrigel, an artificial basement mem­
brane prepared from Engelbreth Holm Swarm sarcoma of mice [155, 156, 4]. Impli­
cation of stroma as an intermediate in the induction of proliferation in epithelium 
was shown when uterine or vaginal epithelium were recombined with stroma in a 
collagen gel and grown under the kidney capsule in mice; the epithelium responded 
to estrogen by increased cell division [157]. An attempt to duplicate this interaction 
using mouse uterine epithelial and stromal cells cocultured on tissue culture plastic 
in the absence of the complex humoral milieu of the intact mouse showed an overall 31 
increase in thymidine incorporation in response to estradiol [129]. Unfortunately, 
no attempt was made to exclude the possibility that the increased incorporation in­
cluded or was due exclusively to stromal cells. Thus, despite considerable indirect 
evidence suggesting that stroma mediates the hyperplastic response of epithelium 
to estradiol, the question still has not been rigorously tested. 
We have investigated this question using primary isolated mouse uterine 
epithelial and stromal cells cocultured or cultured separately. The proliferative 
response of morphologically and immunocytochemically identified stromal and ep­
ithelial cells to estradiol was directly observed by the visualization of 5-bromo-2­
deoxyuridine incorporated into in nucleus during DNA.synthesis. We confirm that 
epithelial cells require interaction with stromal cells for this response and that pro­
liferation in the interacting stromal cells is also enhanced by physiological levels of 
17,3-estradiol. We also demonstrate by analysis of specific cell groupings that the 
response requires either physical contact or short range signals between epithelial 
and stromal cells. 
2.3  Materials and Methods 
2.3.1  Materials 
DMEM/F12 mixture was purchased from Gibco (Grand Island, NY). Tissue cul­
ture supplements, 170-estradiol, trypsin, pancreatin V, collagenase IV, extravidin, 
and 2,3 diaminobenzidine were purchased from Sigma (St. Louis, MO). Polyclonal 32 
Cytokeratin Immunostaining Kit was purchased from BioGenex (San Ramon, CA). 
Monoclonal antibody against 5-bromo-2-deoxyuridine was purchased from DAKO 
Corporation (Carpenteria, CA). Anti-mouse IgG conjugated to biotin was pur­
chased from Vector (Burlingame, CA). The chromogen 4-chloro-l-naphthol was 
purchased from BioRad (Richmond, CA). 
2.3.2  Animals 
Immature and 6-week old female CF-1 mice were purchased from Charles River 
Laboratories (Wilmington, MA) or bred and raised in the facility at this university. 
Mature CF-1 females (6 weeks old) were staged for early estrus of the estrous cycle 
by vaginal lavage [39], and sacrificed by cervical dislocation immediately before 
each experiment. Immature females were sacrificed between 21 and 25 days after 
birth. Animals were maintained by the University Laboratory Animal Resources 
staff in accordance with NIH guidelines and fed ad libitum. 
2.3.3  Cell Culture 
Uteri were cleaned of fat and mesometrium then slit open longitudinally and cut 
into four pieces.  Uteri were washed with Hanks' Balanced Salt Solution (BSS) 
followed by calcium- and magnesium-free BSS (CMF). Epithelial cell flakes were 
isolated by trypsin and pancreatin digestion as before [158]. After removal of the 
epithelium, uteri were incubated in CMF for 20 minutes then triturated gently 
with a wide bore pipette before removing the stroma to decrease the amount of 33 
epithelium contaminating the stromal fraction. Stromal cells were loosened from 
the uteri by digestion with 2.5 mg/ml collagenase for one hour at room temperature 
with gentle shaking on a rotary shaker. After the collagenase was removed, the 
uteri were triturated gently in plating medium with a wide-bore pipette to remove 
cells. The stromal cells were washed twice in plating medium then counted for 
plating. 
The epithelial cell suspension was counted in a hemacytometer, however, 
the densities were used only as estimations for plating since these were not single 
cell suspensions and the number of cells per flake was estimated. An estimated 
plating density between 100 and 200 cells/min' was used for cultures. Actual cell 
densities were determined at the time of fixation of the cultures.  Stromal cell 
suspensions were counted by hemacytometer and plated at the same densities as 
the epithelial cells. Cocultures were prepared by allowing epithelium to attach for 
24 hours then adding an equal number of stromal cells to the culture, as previ­
ously described [129]. Stromal cells used for cocultures were plated into a 25 cm' 
culture flask after the cell isolation and removed from the flask the following day 
by trypsinization then recounted in the presence of Trypan blue before replating. 
Cells were grown on glass coverslips in 35 mm culture dishes to facilitate easy re­
moval of culture for immunocytochemistry. Cultures used for growth curves were 
plated directly into 35 mm culture dishes. 
All cultures were maintained at 37°C in a humidified chamber with 5% 
carbon dioxide and 95% air in a defined, serum-free maintenance medium con­34 
sisting of DMEM/F-12 mixture supplemented with insulin (5pg/m1), transferrin 
(10 µg /ml), hydrocortisone (10-6M), essentially globin free BSA (2mg /ml), peni­
cillin(100 IU /ml) and streptomycin (0.1mg/m1). Plating medium also contained 
fetuin (1mg/m1) and was replaced at 24 hours with maintenance medium. Cultures 
were maintained for four days with daily medium changes to eliminate the possi­
bility of depletion of the medium additives. Steroids were first dissolved in ethanol 
then diluted to the appropriate concentration in medium, with the concentration 
of ethanol never exceeding 0.1% in the culture medium. Cultures were incubated 
with 0.01 M 5-bromo-2-deoxyuridine (BrdU) for 3 hours to label proliferating cells. 
The labeling medium was replaced with medium containing 10-4M thymidine for 
one hour before fixation to remove unincorporated BrdU from the cell cytoplasm 
and decrease background staining during immunocytochemistry. 
2.3.4  Immunocytochemical Staining 
Cultures on coverslips were sequentially immunostained for BrdU and for the ep­
ithelial cell marker, cytokeratin. All incubations were performed at room temper­
ature unless otherwise specified. Covers lips containing cultures were removed from 
culture dishes, rinsed in BSS, and fixed for 15 minutes in 100% methanol at 4°C. 
After fixation coverslips were incubated for one hour at 37°C in 2 N HCI to denature 
the DNA, then neutralized with two rinses of borate buffer followed by PBS (pH = 
7.4). Covers lips were incubated in horse serum diluted in PBS to block nonspecific 
binding. A mouse monoclonal antibody to BrdU was applied and incubated for 35 
one hour at 37°C. Afterward coverslips were incubated for 20 minutes each with bi­
otinylated antibody against mouse immunoglobulin then Extravidin conjugated to 
peroxidase. Covers lips were washed twice with PBS between antibody incubations 
to remove un-bound antibody from the coverslips. The antibody against BrdU 
was visualized using the chromogen 2,4-diamino benzidine (DAB) which produced 
a brown precipitate in nucei containing DNA that had incorporated BrdU. Follow­
ing immunostaining for BrdU, the cultures were immunostained for cytokeratin 
according to the procedure outlined in the manufacturers' directions. The anti­
cytokeratin was visualized by the chromogen 4-chloro-l-Naphthol which forms a 
blue precipitate. Precipitated DAB inhibits local peroxidase activity [159, 160], so 
that the 4-chloro-l-naphthol precipitates specific to areas where  anti-cytokeratin 
binds as long as the DAB background remains low.  If the DAB background is 
high all of the peroxidase activity is inhibited and none of the 4-chloro-l-naphthol 
precipitates. Initially primary or secondary antibodies were replaced with  diluted 
serum or PBS to determine background staining. Both PBS and serum produced 
the same results, therefore, PBS replaced for the primary antibodies was used as 
the control for each subsequent experiment. 
2.3.5  Gathering and Analysis of Data 
A glass reticle etched with a 0.6 mm2 grid hatch-marked into 100 square fields was 
used to count cells. A starting point within the immunostained area was chosen 
at random, and neighboring fields were counted as in the method of counting cells 36 
on blood smears [161]. The number of fields counted on each slide was used to 
determine the cell density of each slide. Counting continued until 2000 cells had 
been counted for each slide and catagorized according to cell type, the presence of 
incorporated BrdU, and the cell types each cell was physically contacting. 
One-tailed simple sign tests [162] were used to test the hypothesis that 
estrogen-treatment of cocultured cells increased the number of labeled cells per 
the total cells counted from a treatment group, and the hypothesis that estrogen-
treatment of monocultured cells decreased the number of labeled cells per the 
total cells counted from a treatment group.  Cell count data was also analyzed 
graphically. 
2.4  Results 
2.4.1. Growth and Purity of Cultures 
Epithelial cells were dislodged from the luminal surface of the uterus in flakes 
that maintained their cellular junctions during the isolation and culture proce­
dures. Typically, central cells in the flake were more rounded, and divided more 
frequently than the flattened cells on the periphery. Cells isolated from adult mice 
that were initially associated as flakes at plating often separated from one another 
during culture and formed loosely attached groups (see Figure 2).  These cells 
maintained a polygonal shape and size similar to cells on the periphery of conven­
tional epithelial flakes and maintained some cell contacts to their nearest neighbors 37 
through thin, stretched cytoplasmic processes. These cells divided more often than 
cells in typical flakes. It is likely that the increased proliferation resulted from the 
loss of contact inhibition as the cells separated from one another. Immunostaining 
for the localization of a polyclonal antibody to human cytokeratin showed that all 
of these cells contained cytokeratin, however, they were less immunoreactive to the 
anti-cytokeratin than cells in typical flakes which were similarly flattened. 
The baseline growth rates of epithelial and stromal cells at various densities 
were estimated by continuous observation of marked areas in cultures maintained 
in a defined, serum-free medium on tissue culture plastic. The number of cells 
in a randomly chosen 0.175 mm2 area on the culture dish was counted 12 hours 
after plating. This area was then marked and monitored during six days of culture 
at 12 hour intervals (see Figure 3).  Epithelial flakes required up to 24 hours to 
orient their basal surface downward and attach to the culture substrate, therefore, 
24-hour cultures were used to assess the number of cells successfully plated. 
Epithelial cells isolated from the uteri of immature mice grew better and 
were more predictable than cells isolated from adult mice. A summary of the 
proliferation rate for cell densities at 24 hours after plating is included in Table 1. 
Optimal densities spanned a large range especially for epithelial cells isolated from 
immature mice. 38 
a  b 
` tv+ 
fee 
-
/ 
7--* 
/
.  #4.Sr% 
*10 
I1 °  b 1 
fi  ;  "0141w1 
1 
d
Figure 2. Epithelium isolated from adult mice in early estrus after three days of culture. Cultures 
were labeled with BrdU three hours before fixation, then double immunolabeled for cytokeratin 
(at arrow) and BrdU (at arrowhead and throughout the flake). Phase contrast (a,c) and bright 
field (b,d) photographs of the same field are included to highlight both cell morphology and 
immunostaining. Note that the cells in the upper portion of the photo (a,b) are separated from 
one another and maintain a higher rate of proliferation than the cells in the typical epithelial flake 
in the lower portion of the photo. Also, the cytoplasmic stain for anti-cytokeratin is less intense 
in the cells that constitute the separated flake. Only the typical epithelial flake morphology was 
present in cultures of cells isolated from immature mice. An epithelial culture incubated with 
PBS in place of anti-BrdU and anti-cytokeratin is included (c,d) to demonstrate background 
staining. x 344. 39 
Epithelium 
1250  1250 
A 
1000  1000 
N 
750- 750­
Tn 500- 500
250- 250­
I I 1  1 1 0 0 
1  2 3 4 5 6  0  1  2  3  4 5 6 
days  days 
Stroma 
1250  1250 
D
1000  1000­
N 
750  750­
E
500 a500­ .) 
250- 250­
0  I i t  0  I I 
0  1 2 3 4 5 6  0  1  2 3 4 5  6 
days  days 
Figure 3. Growth of epithelium and stroma in serum-free culture. Cultures were maintained 
in a defined, serum-free medium for six days. The number of cells was recorded every 12 hours 
for several areas in each culture. A summary of the growth rates of epithelium isolated from 
immature mice (A) or adult mice in early estrus (B), and stroma isolated from immature mice 
(C) or adult mice in early estrus (D) plated at varying densities is shown. Each line represents 
the averaged growth of several areas that had similar starting densities.  Each point is the 
average number of cells/mm2 from at least three areas. Bars represent +S.E. Points without 
bars represent less than three observations. Note that cells isolated from immature mice (graphs 
on the left) increase in number during six days of culture. Whereas, the cells isolated from adult 
mice (graphs on the right) maintain their culture density or double once during the six days. 40 
Table 1. Growth rates of uterine cells cultured in a defined, serum-free medium. Numbers 
represent the density (cells /mm2) at 24 hours after plating. 
.  Cell type 
Rate of  Epithelium  Epithelium  Stroma  Stroma 
Proliferation  Immature  Adult  Immature  Adult 
no significant doubling  < 2  < 25  < 14  < 20 
doubling time 1-3 days  3-100  27-150  60-100  60-100 
rapid division then decline  > 120  > 80 
In preliminary experiments (not shown), the purity of stromal and epithe­
lial monocultures was observed by comparing immunostaining for cytokeratin and 
vimentin. As expected, stromal cells did react selectively with antibodies against 
vimentin, but not. with anti-cytokeratin. Epithelial cells reacted selectively with 
anti-cytokeratin, but not anti-vimentin. The purity of the epithelial and stromal 
monocultures is described in Figure 4. Occasionally epithelial flakes were observed 
in stromal cultures.  If stromal cells contaminated epithelial cultures, they were 
usually associated with each other as groups or whorls. The stromal cells which 
formed whorls in culture were not fibroblastic in appearance, and were proba­
bly myeloid-derived cells from the uterine stroma. Epithelial cells isolated from 
adult mice were contaminated with stromal cells more frequently than epithelium 
from immature mice. Yet stromal contamination was never higher than 4% in 
any epithelial monoculture (see Figure 4). Although the epithelial contamination 41 
of stromal monocultures occasionally reached as high as 20%, the percentage of 
epithelial cells which contacted stromal cells in these cultures was always less than 
1%. Epithelial and stromal cells isolated from either immature or adult mice were 
observed during 6 days to determine baseline division at various densities (see Fig­
ure 3). In all experiments only specifically identified cells were used in calculations. 
100%  < 3% < 20%
<8%  <  14%  < 3%  cn 
(1) < 4%
75 % < 5% 
O 
O  < 1%
,,,c) 50% < 1% 
-
< 1%
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Figure 4. The purity of uterine cell monocultures. The bars represent all of the monocultures 
pf epithelial and stroinal cells. They are divided into fractions representing the percent of the 
population that contained each level of contamination of the other cell type. Numbers inside of 
the bars indicate the percentage of contaminating cell type present in each fraction. 
A coculture response, determined by at least a doubling of proliferating cells 
in E2-treated cultures, was observed only when the minor cell type constituted at 42 
least 25% of the total cell population in the coculture. Three quarters of stromal 
cultures isolated from adult mice ranged between 190 and 400 cells/mm2 at fixa­
tion, and 80% of the stromal cultures isolated from immature mice ranged between 
60 and 600 cells/mm2 at fixation. Whether they were isolated from immature or 
adult mice, 67% of the epithelial cultures ranged between 90 and 430 cells/mm2. In­
cluding both cell types, 80% of the cocultures were between 100 and 475 cells/mm2 
at the time of fixation. 
2.4.2  Effects of Steroid Treatment on Proliferation 
Epithelial proliferation increased significantly in cocultures treated with 8 x 10' 
M 170-estradiol for 24 hours. Proliferation of the stromal cells within the cocul­
tures also increased in response to treatment with 17/3-estradiol, but to a lesser 
degree (see Figures 5, 6 and 7). The fraction of cocultured epithelial cells from im­
mature mice incorporating BrdU increased by 1.5-fold, while those from adult mice 
in early estrus showed a 4-fold increase. Experiments involving cells isolated from 
adult mice showed more variability, most likely resulting from the different pop­
ulations of epithelial cell flakes which made up most cultures as well as the more 
variable plating densities and growth rates observed in cultures of cells isolated 
from adult mice. The number of cocultured immature stromal cells that incorpo­
rated BrdU increased 2-fold above the control with estrogen treatment. Stromal 
cells isolated from both immature or adult mice increased proliferation in response 
to estrogen-treatment in coculture with the variability again higher in cells isolated 43 
from adult mice. Estrogen stimulated proliferation of stroma cells only when they 
were cocultured with epithelium. Thus, it appears that  the stromal-epithelial in­
teraction that is required for estrogen-induced epithelial proliferation is reciprocal. 
Although proliferation was stimulated in cocultured stromal cells less than 
in epithelial cells, stromal cells accounted for the majority of the cells that incor­
porated BrdU in each coculture. The number of BrdU-labeled stromal cells ranged 
between 60 and 230 per thousand cells, for experiment densities other than those 
with less than 40 cells/mm2 or greater than 900 cells/mm2. Epithelial cells ranged 
between only 5 and 60 labeled cells per thousand cells consistently. 
Cells within the cocultures differed by the types of cell-cell contacts they 
maintained at the time of treatment and fixation of the culture. When the pop­
ulation of cells counted for each coculture was divided into groups of cells that 
maintained the same types of cell-cell contacts, the estrogen-stimulated increase of 
proliferation in immature epithelial cells occurred in approximately 80% of epithe­
lial cells which physically contacted both epithelial and stromal cells (see Figures 8 
and 9). Similar results were obtained when the stromal cell population was grouped 
according to their. cell-cell contacts. However, the response of stromal cells that 
physically contacted both epithelium and stroma to estradiol was more variable. 
This group of stromal cells appeared to be divided into one group that increased 
proliferation with estrogen-treatment and one group that remained near control 
levels of proliferation (see Figures 8 and 9). This type of variability may indicate 
that other factors within this culture system could have affected the response of 44 
these stromal cells to estradiol. 
Treatment of either epithelial or stromal monocultures with 8 x 10' M 17/3 
estradiol for 24 hours suppressed proliferation (see Figures 10 and 11). The number 
of labeled nuclei in monocultures of either immature epithelium or stroma treated 
with 8 x 10' M 17,3-estradiol were 50% and 20% lower than non-treated control 
cultures, respectively.  Estrogen inhibited monocultured epithelium and stroma 
isolated from adult mice by 20% and 50%, respectively. A similar suppression 
of proliferation by estrogen was recently reported for mouse uterine epithelium 
cultured on Matrigel or collagen substrates [156]. 
The estradiol-stimulated increase in the incorporation of BrdU in cocultures 
was inhibited by treating the cocultures concurrently with either 1.8 x 10' M or 
1.8 x 10' M tamoxifen (see Figure 12), a weak antiestrogen shown to inhibit 
estrogen-stimulated upregulation of progesterone receptors in cultured mouse en­
dometrial cells [163].  Treatment of cocultures with tamoxifen alone did not 
reduce or increase the proliferation of either cell type, so subsequent controls for 
these experiments were treated with tamoxifen alone. 45 
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Figure 5. Changes in proliferation in response to estrogen-treatment of monocultures and co­
cultures of uterine cells isolated from immature mice. The amount that proliferation increased 
or decreased from the control was determined by dividing the number of cells that incorporated 
BrdU per 1000 cells in the estrogen-treated culture by the number of cells that incorporated 
BrdU per 1000 cells in its parallel control culture (.). The amount of control proliferation is 
represented by 1 on the y-axis. The bars represent the median increase or decrease of prolifera­
tion from the control cultures. Cells from the same isolation were plated for paired control and 
estrogen-treated cultures in each experiment. There were at least 10 cell isolations per group. 
Increases in proliferation of epithelial cells (P = 0.002) and stromal cells (P = 0.0899) within 
cocultures treated with estradiol were analysed by one-tailed simple sign tests. The same method 
was used to analyze the suppression of proliferation in estradiol-treated epithelial monocultures 
(P = 0.0547) and stromal monocultures (P = 0.017). 46 
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Figure 6. Estrogen-induced changes in proliferation of monocultured and cocultured uterine 
cells isolated from adult mice in early estrus. Experiments were conducted in the same manner 
as explained for cells isolated from immature mice in the legend to Figure 5. The bars represent 
the median of the fold-change in proliferation as compared to the parallel control cultures. The 
fold-change in proliferation for each experiment is shown (). Paired estrogen-treated and control 
cultures were from the same cell isolation, and there were at least 10 cell isolations per group. 
The level of control proliferation is represented as 1 on the y-axis. C 
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Figure 7. Estrogen-induced proliferation of cocultured endometrial cells isolated from immature 
mice. Cultures were maintained in control serum-free medium (a,b) or treated with 8 x 10-9 M 
17)3-estradiol (c,d), then labeled with BrdU three hours before fixation. They were double im­
munolabeled for anti-BrdU (arrow) and anti-cytokeratin (at arrowhead and throughout flake) 
(a,b). Phase contrast (left) and bright field (right) pictures of the same field are included to 
highlight both cell morphology and immunostaining. x 344. .  48 
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Figure 8. Estrogen-induced proliferation of cocultured uterine cells isolated from immature 
mice and grouped according to their cell-cell interactions within the culture. The number of 
proliferating cells per thousand in each estradiol-treated culture was divided by the number 
of proliferating cells per thousand in each parallel control culture (.). The bars represent the 
median for each group. In order to determine whether direct contact effected estrogen stimulation 
of proliferation, all cells counted in the cocultures were grouped accordingly: epithelial cells with 
no contacts (E), epithelial cells touching other epithelial cells (EE), epithelial cells touching only 
stromal cells (ES), epithelial cells contacting both cell types (E-ES), stromal cells with no contacts 
(S), stromal cells touching other stromal cells (SS), stromal cells touching only epithelial cells 
(SE), and stromal cells contacting both cell types (S-ES). Note that the largest estrogen-induced 
increase in proliferation is in the group of epithelial cells directly contacting both other epithelial 
cells and stromal cells. 49 
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Figure 9. Estrogen-induced proliferation of uterine cells isolated from adult mice in coculture 
grouped according to their cell-cell interactions within the culture. The number of proliferating 
cells per thousand in each estradiol-treated culture was divided by the number of proliferating cells 
per thousand in each parallel control culture (). The control level of proliferation is represented 
as 1 on the y-axis. The bars represent the median for each group. In order to determine whether 
direct contact effected estrogen stimulation of proliferation, all cells counted in the cocultures 
were grouped accordingly: epithelial cells with no contacts (E), epithelial cells touching other 
epithelial cells (EE), epithelial cells touching only stromal cells (ES), epithelial cells contacting 
both cell types (E-ES), stromal cells with no contacts (5), stromal cells touching other stromal 
cells (SS), stromal cells touching only epithelial cells (SE), and stromal cells contacting both 
cell types (S-ES). Note that the variation is higher for cells isolated from adult mice than cells 
isolated from immature mice (Figure 8), however, similar trends are apparent. The increased 
proportion of estrogen-stimulated proliferation in epithelial cells not contacting stromal cells 
probably resulted from the presence of separated flakes in these cultures. 50 
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Figure 10. The estrogen-induced suppression of proliferation in monocultured uterine epithelial 
cells isolated from immature mice. Epithelial monocultures were maintained in control serum-free 
medium (a,b) or treated with 8 x 10-9 M 17,3-estradiol (c,d), then labeled three hours with BrdU 
before fixation. Cultures were double-immunolabeled for anti-BrdU (arrow) and anti-cytokeratin 
(at arrowhead and throughout flake) (a,b).  Epithelium treated with 17,3-estradiol shows de­
creased proliferation from the control culture in these similarly sized epithelial flakes.  Phase 
contrast (left) and bright field (right) pictures of the same field are included to highlight both 
cell morphology and immunostaining. x 422. 51 
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Figure 11. The estrogen-induced suppression in proliferation of monocultured uterine stromal 
cells isolated from immature mice. Stromal monocultures were maintained in control serum-free 
medium (e,f) or treated with 8 x 10-9 M 17/3-estradiol (g,h), then labeled three hours with BrdU 
before fixation. Cultures were double-immunolabeled for anti-BrdU (arrow) and anti-cytokeratin 
(no immunoreactivity). Treatment of stromal monocultures with 17[3-estradiol reduced the pro­
liferation of the stromal cells, although this is not readily apparent from examining the cultures 
visually. Phase contrast (left) and bright field (right) pictures of the same field are included to 
highlight cell morphology and immunostaining. x 422. 52 
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Figure 12. Tamoxifen inhibited estrogen-induced proliferation in cocultured stromal and ep­
ithelial cells. The number of proliferating cells per thousand in the estradiol-treated or estradiol­
and tamoxifen-treated culture was divided by the number of proliferating cells per thousand in 
the parallel control culture treated with tamoxifen alone. The control level of proliferation is 
represented as 1 on the y-axis. The bars representing uterine cells isolated from immature mice 
include only one experiment. The bars representing uterine cells isolated from adult mice show 
the mean of two experiments. 53 
2.5  Discussion
Through direct examination of cell morphology and BrdU incorporation during 
culture in a defined, serum-free medium, we have shown that estrogen increases 
the proliferation of epithelial cells only when they are cocultured with stromal cells. 
While in vivo studies in ovariectomized and immature mice have shown that prolif­
eration increases dramatically in response to estrogen [73], there is still debate as to 
whether estrogen exerts this effect directly through binding to estrogen receptors 
within the uterine epithelium or via some kind of stromal mediation. Neonatal mice 
injected with 17/9- estradiol prior to the presence of estrogen receptors in the uter­
ine epithelium showed increased epithelial proliferation and secretory activity in 
response to estrogen [130]. Estrogen receptors are not present in the mouse uterine 
epithelium until 3-5 days after birth depending on the strain of mouse [131, 130], 
but stromal cells contain estrogen receptors during uterine development, sexual 
immaturity, and adulthood in rodents [164]. The uterine epithelial cells should 
not have been able to respond to estrogen stimulation in these experiments if 
estrogen acts on the epithelium through its own estrogen receptors.  Epithelial 
and stromal tissues were isolated from ovariectomized adult mice, recombined in 
collagen, then transplanted under the kidney capsule of adult female mice. The 
epithelium in these implants proliferated in response to estrogen rises during the 
estrous cycle [157]. These experiments were all performed in vivo where the cells 
still had access to plasma-borne hormones and growth factors, and the possibility 54 
that endocrine-acting factors in the plasma were affecting the epithelium could not 
be excluded. 
Estrogen has never been shown to increase the proliferation of mouse uter­
ine epithelium cultured alone on plastic or on various matrices [4, 156, 152]. How­
ever, uterine epithelium cultured on substrates, including Matrigel (an artificial 
basal lamina produced by Engelbreth Holmes Swarm Sarcoma cells), collagen, 
or Matrigel-coated filters does respond to estrogen by hypertrophy and increased 
production of various proteins that are known to be stimulated by estrogen in 
vivo [4]. Hypertrophy [91] and increased production of specific estrogen-inducible 
proteins [165] are known to occur more quickly after estrogen stimulation in vivo 
than the onset of increased DNA replication and cell division [73, 86]. These ex­
periments provide evidence that estrogen exerts some effects on the epithelial cell 
directly through binding to the epithelial estrogen receptors, but that the stimu­
lation.of proliferation requires a more complex series of events, probably involving 
the stroma. 
We have demonstrated that in addition to the stimulation of epithelial pro­
liferation by estradiol in epithelial-stromal cocultures stromal cells are also stimu­
lated, albeit to a lesser extent. In vivo experiments measuring changes in tritiated 
thymidine incorporation, mitoses, nuclear volume, tritiated cytidine incorporation 
into RNA, and nucleolar volume have also shown slight stimulation of the stroma 
24 hours after estrogen injection into ovariectomized mice without progesterone 
priming [111, 86, 110, 73]. However, the epithelium makes up only 5-10% of the 55 
uterus by mass, whereas the stroma makes up 30-35% of the uterus [112], there­
fore, measurements of estrogen-induced incorporation of tritiated thymidine into 
the whole uterus, whole endometrium, or cocultured stroma and epithelium [129] 
is not representative of the response of epithelium alone. The accurate measure­
ment of the estrogen-induced proliferative response in uterine cells requires that 
proliferating cell types be identified specifically. 
We found that the proliferation of stromal and epithelial cells cultured sep­
arately was suppressed by treatment with estrogen. This was also recently shown 
for mouse uterine epithelium cultured on plastic, collagen, or Matrigel substrates 
by measuring BrdU incorporation [156]. There are a number of possible expla­
nations for this reduction. Fukamachi and McLachlan hypothesized that estrogen 
protected the cultured epithelial cells against apoptosis (programmed cell death), 
and this resulted in a slower division rate and fewer cells detaching from the sub­
strate [156].  However, they did not measure detached cells or cell death directly 
in these cultures. It is also possible that estrogen shifts the cell's physiology away 
from one preparing for cell division, and towards one that emphasizes the produc­
tion of estrogen-induced proteins and secretory products unrelated to cell division. 
Increased protein production is stimulated by estrogen in monolayer cultures of 
epi thelium. 
We have shown that epithelial cells maintaining physical contacts to both 
epithelial and stromal cells in coculture constitute the majority of the cells stimu­
lated to proliferate in the presence of estradiol in vitro. Using transmission electron 56 
microscopy, epithelial projections through the basement membrane that connect to 
stromal cells and other epithelial cells via gap junctions have been shown to increase 
following the increasing concentration of circulating estrogen during the menstrual 
cycle in human endometrium [32]. The number of gap junctions on these processes 
also increase with increasing plasma estrogen levels, indicating that increased corn­
muncation between stromal and epithelial cells and between epithelial cells may 
result during estrogen stimulation. Taken together this evidence supports the hy­
pothesis that direct contact is required for stromal mediation of estrogen action on 
epithelial proliferation in the uterus. Alternatively, stromal cells may be secreting 
short-lived epithelial proliferation factors into the area immediately surrounding 
the epithelial cell in response to estrogen action in the stroma. A possible mecha­
nism for such factors may be gene derepression. If genes required for cell division 
are being constitutively repressed without stromal cell intervention in response to 
estrogen, the stromal cell, could release factors that remove this repression. One 
experiment examining the effect of stromal-conditioned medium on epithelial cells 
did not result in a difference in proliferation between estrogen treated and control 
cultures [129]. However, the possibility that a short-lived factor is released from the 
stroma and requires close contact between stromal and epithelial cells still could 
not be ruled out. The short-lived factor could influence epithelial cells directly, as 
a growth factor, or alter the extracellular matrix, as a matrix-degrading enzyme, 
to cause the movement of growth factors bound to ECM molecules to the higher 
affinity epithelial cell surface receptors. The factor may also act directly on the 57 
epithelial cell to alter its interaction with the matrix through regulating the cell 
surface matrix receptors which could cause the epithelial cell to change shape and 
alter cell proliferation [166, 18, 22]. 
Previous whole animal or organ culture studies have implicated the stroma 
as a mediator of estrogen-induced proliferation of epithelium [167, for a review]. 
However, the only attempt to directly examine the role of isolated stromal cells in 
estradiol-induced epithelial cell proliferation was ambiguous because no attempt 
was made to identify responding cell types [129]. The present work demonstrates 
for the first time by direct examination of responsive cell types in vitro, that uter­
ine epithelial cells require close association with stromal cells for a proliferative 
response to estradiol. Furthermore, the interaction between epithelial and stromal 
cells appears to be reciprocal in that stromal proliferation in response to estradiol 
also requires association with epithelial cells. The results provide strong evidence 
for either direct stromal-epithelial contact or the release of short-lived factors from 
the stroma that act only within the very short distances between these two inti­
mately associated cell populations. 58 
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Appendix A
Summary of Data72 
Table 2. Estrogen-induced proliferation of cocultured epithelium and stroma isolated from im­
mature mice. The left side of each column summarizes the number of BrdU-labeled cells per 
1000 cells for each experiment. The density of each culture at fixation (in cells/mm2) is included 
on the right side of each column. Each row includes data from one cell isolation. 
Control  Estrogen-Treated  Control  Estrogen-Treated 
Epithelium  Epithelium  Stroma  Stroma 
labeled  density  labeled  density  labeled  density  labeled  density 
nuclei  nuclei  nuclei  nuclei 
15  26  108  46  181  72 216  72 
20  21 26  294 30  62 181  136 
16  178  36  182  194  249  177  462 
11  83  49  90  161  153  222  173 
37  163 54  134 73  23 100  23 
27  93  61  477  147  107  133  175 
43  345  63  307  102  121  182  53 
26  37 41  103 58  100 97  138 
21  99  30  281  79  173  110  190 73 
Table 3. The suppression of proliferation in response to estrogen-treatment of monocultured 
epithelium and stroma isolated from immature mice. The left side of each column summarizes 
the number of BrdU-labeled cells per 1000 cells for each experiment. The density of each culture 
at fixation (in cells/mm2) is included on the right side of each column. Each row includes data 
from one cell isolation. 
Control  Estrogen-Treated  Control  Estrogen-Treated 
Epithelium  Epithelium  Stroma  Stroma 
labeled  density  labeled  density  labeled  density  labeled  density 
nuclei  nuclei  nuclei  nuclei 
43  90  5.5  103 
6  114  8.5  75  53  24  45  22 
11  84 7  65 74 
15  116  5.5  145  101  335  87  137 
12  149  12.5  140  87  332 
22  191  13  385 29  13  19  19 
54  262 28  165 29  15 41  11 
107  66 87  85 
56  95 21  151 121  90 97  119 
64  553  53  600 
59  199 32  264 91  88 65  85 
84  86 73  69 
77  1397  37  950 
47  86 27  124  77  177 74 
Table 4. The suppression of proliferation in response to estradiol-treatment of monocultured 
epithelium and stroma isolated from adult mice. The left side of each column summarizes the 
number of BrdU-labeled cells per 1000 cells for each experiment. The density of each culture 
at fixation (in cells/mm2) is included on the right side of each column. Each row includes data 
from one cell isolation. 
Control  Estrogen-Treated  Control  Estrogen-Treated 
Epithelium  Epithelium  Stroma  Stroma 
labeled  density  labeled  density  labeled  density  labeled  density 
nuclei  nuclei  nuclei  nuclei 
72  58 38  21 46  271 41  301 
21  427 7  737 
37  214  57  103 . 
43  272 5  150 
15  87  11  72 19  37 33  34 
18  119 19  50 17  143 10  41 
81  234  99  225  31  194  21  254 
123  92  115  242  31  232  17  320 
21  238 
34  195  17  394 
3  20  118  142  35  326  31  322 75 
Table 5. Estrogen-induced proliferation of cocultured epithelium and stroma isolated from adult 
mice in early estrus. The left side of each column summarizes the  number of BrdU-labeled cells 
per 1000 cells for each experiment.  The density of each culture at fixation (in cells/mm2) is 
included on the right side of each column. Each row includes data from one cell isolation. 
Control  Estrogen- Treated  Control  Estrogen- Treated 
Epithelium  Epithelium  Stroma  Stroma 
labeled  density  labeled  density  labeled  density  labeled  density 
nuclei nuclei  nuclei  nuclei 
63  58 82  43  15  192 24  37 
36  116  76  80 43  12  36  23 
36  14 244  6  101  24 145  24 
2  41  7  49 16  131 24  204 
7  2 48  5  11  32 6  81 
43  229 9  81 38  89  4  394 
9  36  42  74  19  204  15  372 
9  94  39  151  10  452  67  290 76 
Appendix B 
Supporting Experiments 
B.1 Measurement of Estradiol Stimulation by Incorpora­
tion of 3H-Thymidine 
Preliminary experiments were modeled after Inaba et al. [129], and used the incor­
poration of tritiated thymidine into the nuclei of cells synthesizing DNA during a 
one hour labeling period. The measurement of the proliferation of epithelial and 
stromal monocultures or cocultures in this manner was inconclusive. Variability of 
the densities of cultures within and between experiments contributed strongly to 
the variability in these experiments. Using this method it was not possible to quan­
tify which cell type incorporated the label in these cultures. Some of the variability 
in data from monocultured cells may have been due to low purity of monocultures. 
Inconsistent stromal/epithelial cell ratios in cocultures probably contributed to 
differing amounts of stimulation and increased variability in data from cocultures. 
These experiments were based on the amount of protein in each homogenate, and 77 
estrogen-stimulation of increased protein production could have masked increases 
in proliferation in cocultures. Tables  6, 7 and 8 show a summary of the results 
of these experiments recorded in DPM /µg protein. Suppression of proliferation by 
estrogen-treatment of monocultures is present for most monocultures. However, 
estrogen-treatment of cocultures show no evident trends. 
Table 6. Changes in proliferation resulting from estrogen-treatment of mono- and cocultured 
epithelium and stroma isolated from adult mice in estrus. Numbers reported are DPM of incor­
porated tritiated thymidine per jig protein in each culture extract. Two types of medium bases 
were used in these experiments: Medium 1 base was deficient DMEM/F-12  (sigma) with compo­
nents readded except for phenol red. Medium 2 was complete DMEM/F-12 (Gibco) containing 
phenol red. 
Medium  Control  Estrogen- Control  Estrogen- Control  Estrogen-
Type  Treated  Treated  Treated 
Epithelium  Epithelium  Stroma  Stroma  Coculture  Coculture 
Medium  152  83  21  20  141  51 
1  113  85  4  4  73 202 
4  2 49 21  3  2 
Medium  196  236  37  63  86  89 
2  65  76  6  5 634 105 
1  18 38 22  2  1 78 
Table 7. Changes in proliferation resulting from estrogen-treatment of mono- and cocultured 
epithelium and stroma isolated from immature mice in estrus. Estrogen-response of mono- and 
cocultured epithelium and stroma isolated from immature mice. Numbers reported are DPM 
of incorporated tritiated thymidine per pg protein in each culture extract. The description of 
Media types is included legend of Table 6. 
Medium  Control  Estrogen- Control  Estrogen- Control  Estrogen-
Type  Treated  Treated  .  Treated
Epithelium  Epithelium  Stroma  Stroma  Coculture  Coculture 
Medium 18 22  1  1  3  2 
1 '58  65 4 4  32 32 
Medium 31  15  7  8  20  55 
2  43  35  12 13  31 40 
Table 8. Changes in proliferation in response to estrogen-treatment of mono- and cocultured 
epithelium and stroma isolated from four week old mice. Numbers represent DPM of incorporated 
tritiated thymidine per pg protein in each culture extract. The description of Media types is 
included legend of Table 6. 
Medium  Control  Estrogen- Control  Estrogen- Control  Estrogen-
Type  Treated  Treated  Treated
, 
Epithelium  Epithelium  Stroma  Stroma  Coculture  Coculture 
Medium 18  14  6  4  47  32 
6 1  39 30 6 2  7 
70 Medium 2  25  26  3  3  46 79 
B.2  Immunocytochemistry and Culture Morphology 
Preliminary immunostaining showed that all epithelioid cells which made up flakes 
or groups contained cytokeratin in their cytoplasm.  Cytokeratin localization also 
showed that some epithelial cells did exist as single cells in culture. These cells 
were sometimes polygonal in shape and sometimes more elongated as migrating 
cells. 
Epithelial cultures from adult mice in early estrus contained typical epithe­
lial flakes as well as flakes in which the epithelial cells separated from one another. 
Cells in separated flakes were polygonally shaped and maintained thin, stretched 
connections to their nearest neighbors. These cells were untouched by neighboring 
cells on at least two sides, and divided at unusually high rates when compared to 
epithelium in typical flakes. The most probable explanation of this increased pro­
liferation was the loss of contact inhibition in the separated flakes. The separated 
epithelial cells immunostained for cytokeratin, however, the staining was not as 
strong as in cells in typical epithelial flakes. This could have been due to their 
high division rate since each cell would not have as much time between successive 
divisions to accumulate cytokeratin. It is also possible that these cells are more 
actively migrating, and producing cytoskeletal molecules other than cytokeratin 
because of this. Single cells which appeared migratory contained less cytokeratin 
as measured by relative immunoreactivity. 
Stromal cells exhibited two distinct morphologies in culture. The typical 80 
stromal cell appeared stellate and immunostained for vimentin, an intermediate 
filament found specifically in fibroblasts. A small population of stromal cells ap­
peared in whorls of cells with very small, round nuclei. These cells also immunos­
tained for vimentin, and divided much less often than typical fibroblastic stromal 
cells since it was rare to find this smaller type of stromal cell labeled with BrdU. 
Stromal whorls were present more often in cocultures with very low densities of 
stroma (less than 20%). Cells in the uterine stroma are derived from two lineages, 
paramesonephric ductal mesenchyme and myeloid [1, page 90]: It is probable that 
the stellate, fibroblastic appearing cells are derived from the mesenchyme of the 
paramesonephric duct, and that the smaller cells which appeared in whorls were 
derived from the myeloid lineage. 
Macrophages were common in cultures isolated from immature animals, but 
were rarely present in cultures isolated from adult mice. Macrophages were present 
in or near epithelial flakes.  They sometimes stained positively for cytokeratin, 
but not for vimentin (however, very few were present in vimentin immunostained 
slides so this may have been an unfair sample size). These cells contained between 
2 and 18 nuclei per cell, almost always being an even number. Either all nuclei 
incorporated 5-bromo-2-deoxyuridine or none within a single cell, and size was 
within an appropriate range for macrophages. 81 
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Figure 13. Mouse uterine epithelium double-immunostained using DAB for anti-BrdU (brown) 
and 4-chloro-l-napthol for anti-cytokeratin (blue). Phase contrast (a) and bright field (b) pictures 
of the same field are included to highlight both cell morphology and immunostaining. Note that a 
mitotic figure (arrow) which incorporated BrdU during the three hour labeling period is present. 
x 1260. 82 
Figure 14. Mouse uterine stroma double-immunostained using DAB for anti -BrdU (brown) and 
4-chloro-l-napthol for anti-cytokeratin (blue). Phase contrast (a) and bright field (b) pictures of 
the same field are included to highlight cell morphology and immunostaining. x 1260. 